Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures
Authors:
- A. O OnbasiliAOA. O Onbasili
- Y. YenicerigluYYY. Yeniceriglu
- P. AgaogluPAP. Agaoglu
- A. KarulAKA. Karul
- T. TektenTTT. Tekten
- H. AkarHAH. Akar
- G. DiscigilGDG. Discigil
Abstract
To evaluate the efficacy of trimetazidine (TMZ) in the prevention of contrast-induced nephropathy (CIN) in patients with high serum creatinine levels undergoing coronary angiography/angioplasty. TMZ (20 mg thrice daily) was administered orally for 72 h starting 48 h before the procedure. All patients were given intravenous saline (0.9%) at a rate of 1 ml/kg of body weight per hour for 24 h starting 12 h beforehand. Serum creatinine levels were measured before the procedure, 48 h and 7 days after the procedure. Increase in serum creatinine level exceeding 0.5 mg/day or one quarter of the basal value is considered as CIN. Venous blood samples for serum total antioxidant capacity (TAC) measurement were drawn before and after coronary angiography. Basal serum creatinine levels and TAC were similar in TMZ and control groups. Serum creatinine levels in the control group increased significantly 2 days after the procedure, and returned to the baseline values on the seventh day. However, it did not change significantly on the second day, and even significantly decreased on the seventh day in the TMZ group. CIN developed in 2.5% (1/40) of patients in the TMZ group and in 16.6% (7/42) of patients in the control group (p<0.05). TAC values were not different between treatment groups. TMZ along with isotonic saline infusion is more effective than isotonic saline alone in reducing the risk of CIN in patients with pre-existing renal dysfunction.Keywords
This publication has 52 references indexed in Scilit:
- Contrast Nephropathy After Coronary AngiographyMayo Clinic Proceedings, 2004
- Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiographyAmerican Heart Journal, 2003
- The Prevention of Radiocontrast-Agent–Induced Nephropathy by HemofiltrationNew England Journal of Medicine, 2003
- Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrastCatheterization and Cardiovascular Interventions, 2003
- Oxidant mechanisms in toxic acute renal failureAmerican Journal of Kidney Diseases, 1997
- Contrast‐induced nephrotoxicity in patients undergoing cardiac catheterizationCatheterization and Cardiovascular Diagnosis, 1994
- Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletionKidney International, 1992
- Contrast Nephrotoxicity: A Randomized Controlled Trial of a Nonionic and an Ionic Radiographic Contrast AgentNew England Journal of Medicine, 1989
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976